...
Considering Comorbidities of Psoriasis as a Basis for Therapeutic Selections
September 24, 2021

  When we think of psoriasis, we often visualize the external manifestations of disease that we can see, such as erythema (redness), induration (thickness), and desquamation (scaling); however, psoriasis is more than cosmetic disfigurement or skin disease. It is a chronic, relapsing, immune deregulatory inflammatory skin and joint disease that has been shown to significantly

...
Now Approved – COSENTYX® (secukinumab): New Expanded Indication in Pediatric PsO, Presented by Novartis.
August 26, 2021

Join Lawrence Eichenfield, MD, Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego, as he discusses the expanded indication of this product. Dr. Eichenfield also serves as the Vice-Chair of the Department of Dermatology at the UC San Diego School of Medicine, and Professor of Dermatology and Pediatrics; and he is board certified

...
Speaking In-Depth with the National Psoriasis Foundation
April 26, 2021

The National Psoriasis Foundation (NPF) provides Dermcast Host, Amber Blair, an in-depth look at their history, growth and key initiatives in 2021.  Amber is joined by NPF’s Chief Scientific and Medical Officer, Dr. Stacie Bell, as well as NPF advocate and derm PA, Jason Oberdick, PA-C from Forefront Dermatology in Pennsylvania.

...
Gum disease as indicator of skin disease
January 13, 2021

Periodontitis, also known as gum disease, is a gum infection that can damage the soft tissue and lead to the destruction of the bone that supports the teeth. It is typically caused by an overgrowth of microbes which leads to an immune-inflammatory response. Dental plaque is a common contributing factor to periodontitis.  Previous studies have